News for '-sun-pharma'

Stock Markets Today: Sensex, Nifty50 End Marginally Higher In Volatile Trade

Stock Markets Today: Sensex, Nifty50 End Marginally Higher In Volatile Trade

Rediff.com25 Feb 2026

Indian equities on Dalal Street saw volatility. Track Sensex, Nifty50 movement and key market drivers for Feb 25, 2026.

STT hike on Futures drags markets down; Sensex crashes 1,547 points

STT hike on Futures drags markets down; Sensex crashes 1,547 points

Rediff.com1 Feb 2026

Benchmark stock indices Sensex and Nifty dived sharply by nearly 2 per cent on Sunday after Finance Minister Nirmala Sitharaman proposed a hike in the Securities Transaction Tax (STT) on derivatives. Reversing the early gains, the 30-share BSE Sensex plunged sharply by 2,370.36 points or 2.88 per cent to slide below the 80,000-mark at 79,899.42 in afternoon trade as the finance minister announced a hike in STT on futures contracts to 0.05 per cent from the current 0.02 per cent.

Sun Pharma acquires US-based Pharmalucence

Sun Pharma acquires US-based Pharmalucence

Rediff.com16 Jul 2014

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Stock Market Today Feb 26, 2026: Sensex, Nifty End Mixed In Volatile Trade

Stock Market Today Feb 26, 2026: Sensex, Nifty End Mixed In Volatile Trade

Rediff.com26 Feb 2026

Indian equity markets experienced a volatile trading day, with the Sensex and Nifty closing almost flat. Market sentiment was influenced by global cues, US-Iran talks, and profit-booking activities.

Sensex reclaims 84K-mark; Nifty ends up 174 points

Sensex reclaims 84K-mark; Nifty ends up 174 points

Rediff.com9 Feb 2026

Benchmark equity indices Sensex and Nifty extended their gains for the second straight session on Monday, driven by optimism over the India-US trade deal and robust buying in public sector banks, consumer durables, and realty stocks.

Sensex sheds 367 points on foreign fund outflows

Sensex sheds 367 points on foreign fund outflows

Rediff.com26 Dec 2025

From the 30-Sensex firms, Bajaj Finance, Asian Paints, HCL Tech, Tata Consultancy Services, Eternal and Sun Pharma were among the biggest laggards. However, Titan, NTPC, Axis Bank, UltraTech Cement, Reliance Industries and Hindustan Unilever were the gainers.

Sensex tanks over 1,000 points, Nifty tumble over 1%

Sensex tanks over 1,000 points, Nifty tumble over 1%

Rediff.com20 Jan 2026

From the 30-Sensex firms, Eternal declined by 4.02 per cent, followed by Bajaj Finance (3.88 per cent), Sun Pharma, InterGlobe Aviation, Trent, Asian Paints, Mahindra & Mahindra and Bajaj Finserv. HDFC Bank emerged as the only gainer from the pack.

Sensex jumps 487 points on optimism over India-EU FTA

Sensex jumps 487 points on optimism over India-EU FTA

Rediff.com28 Jan 2026

From the 30-Sensex firms, Bharat Electronics surged nearly 9 per cent post its December quarter earnings. Eternal, Bajaj Finance, Power Grid, Trent, Mahindra & Mahindra and UltraTech Cement were the other major gainers. Maruti, Sun Pharma, Infosys and Bharti Airtel were among the other laggards.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Stock markets surge nearly 1% on last trading session of 2025

Stock markets surge nearly 1% on last trading session of 2025

Rediff.com31 Dec 2025

From the 30-Sensex firms, Tata Steel, Kotak Mahindra Bank, Reliance Industries, Axis Bank, Titan and Trent were among the biggest gainers. However, Tata Consultancy Services, Tech Mahindra, Infosys, Bajaj Finance and Sun Pharma, were the laggards.

Daiichi Sankyo to offload stake in Sun Pharma

Daiichi Sankyo to offload stake in Sun Pharma

Rediff.com20 Apr 2015

Daiichi won't remain a major shareholder in Sun Pharma.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Stock markets end higher on rally in Infosys shares

Stock markets end higher on rally in Infosys shares

Rediff.com16 Jan 2026

Tech Mahindra, HCL Tech, State Bank of India, UltraTech Cement and HDFC Bank were also among the gainers. In contrast, Eternal, Asian Paints, Bharat Electronics, Sun Pharma and Maruti were among the laggards.

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Rediff.com2 Aug 2019

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore.

Sensex, Nifty tank nearly 1%

Sensex, Nifty tank nearly 1%

Rediff.com9 Jan 2026

From the 30-Sensex firms, NTPC, ICICI Bank, Adani Ports, Bharti Airtel, Sun Pharma and Bajaj Finance were among the biggest laggards. However, Asian Paints, HCL Tech, Bharat Electronics and Reliance Industries were among the gainers.

Sun Pharma surpasses SBI in market valuation

Sun Pharma surpasses SBI in market valuation

Rediff.com17 Mar 2015

TCS is the most valued Indian company.

Sensex down 78 points on weak global trends

Sensex down 78 points on weak global trends

Rediff.com18 Dec 2025

Among Sensex firms, Sun Pharma, Tata Steel, Power Grid, Asian Paints, NTPC and Bharti Airtel were the biggest laggards. Tata Consultancy Services, Tech Mahindra, Infosys, Adani Ports, Axis Bank and HCL Tech were among the gainers.

Why Daiichi's exit is good for Sun Pharma

Why Daiichi's exit is good for Sun Pharma

Rediff.com22 Apr 2015

But splitting management bandwidth by investing in non-core businesses will not be appreciated by the market in the long run.

Sensex jumps 448 points on fresh fund inflows

Sensex jumps 448 points on fresh fund inflows

Rediff.com19 Dec 2025

From the 30-Sensex firms, Bharat Electronics, Power Grid, Tata Motors Passenger Vehicles, Asian Paints, Reliance Industries, and Bajaj Finserv were among the biggest gainers. However, HCL Tech, Kotak Mahindra Bank, ICICI Bank, and Sun Pharma were the laggards.

Norms: US drug regulator warns Sun Pharma

Norms: US drug regulator warns Sun Pharma

Rediff.com1 Sep 2010

The United States Food and Drug Administration has issued a warning letter to it for manufacturing practice violations at its Cranbury facility in New Jersey.

Sun Pharma claims victory over Taro

Sun Pharma claims victory over Taro

Rediff.com8 Sep 2010

Sun Pharma, which was fighting a takeover battle with Israeli pharma major Taro, on Wednesday said that the Supreme Court of Israel has given the ruling in favour of the company.

Sensex slips 43 pts; IT shares fall on profit-taking

Sensex slips 43 pts; IT shares fall on profit-taking

Rediff.com23 Dec 2025

Among Sensex firms, Infosys, Bharti Airtel, Adani Ports, Sun Pharma, Tech Mahindra, Eternal, Axis Bank and Maruti were the major laggards. However, ITC, UltraTech Cement, Tata Steel and HDFC Bank were among the gainers.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Sun Pharma open to large acquisitions post Ranbaxy

Sun Pharma open to large acquisitions post Ranbaxy

Rediff.com25 Mar 2015

Sun Pharma open to large acquisitions post Ranbaxy.

Sun Pharma settles dispute with Astra Zeneca

Sun Pharma settles dispute with Astra Zeneca

Rediff.com4 Aug 2009

Under the agreement, MedImmune has granted Sun Pharma a licence to certain patents, permitting Sun Pharma to continue marketing its generic version of Ethyol in the US.

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Rediff.com22 Apr 2015

The company sold over 21 crore (210 million) shares in Sun Pharma.

Sensex down 376 points on selling in RIL, HDFC Bank

Sensex down 376 points on selling in RIL, HDFC Bank

Rediff.com6 Jan 2026

Reliance Industries cracked 4.42 per cent, while ITC, Kotak Mahindra Bank, InterGlobe Aviation, and HDFC Bank were also among the laggards. However, ICICI Bank, Sun Pharma, Hindustan Unilever, and State Bank of India were among the gainers.

Investors lost Rs 9.40 lakh cr in Budget Sunday crash

Investors lost Rs 9.40 lakh cr in Budget Sunday crash

Rediff.com1 Feb 2026

The market capitalisation of BSE-listed companies eroded by Rs 9,40,581.75 crore to Rs 4,50,61,658.60 crore (USD 4.90 trillion) in a single day.

Stock markets end flat in highly volatile trade

Stock markets end flat in highly volatile trade

Rediff.com28 Nov 2025

Among Sensex firms, Power Grid, Eternal, Bharti Airtel, Axis Bank and Infosys were the biggest laggards. However, Mahindra & Mahindra, Sun Pharma, Kotak Mahindra Bank and State Bank of India were among the major gainers.

Ranbaxy merger: Sun Pharma readies new leadership team

Ranbaxy merger: Sun Pharma readies new leadership team

Rediff.com12 Mar 2015

The group is looking into a new role for Ranbaxy CEO and MD Arun Sawhney.

Sun Pharma wins case against Taro

Sun Pharma wins case against Taro

Rediff.com27 Aug 2008

Sun Pharma, in a filing to the Bombay Stock Exchange, said that the 'Tel-Aviv Court on Tuesday has rejected Taro's contention that Sun Pharma should have conducted a special tender offer under Israeli Law.'

Sensex climbs over 158 points on buying in tech and IT shares

Sensex climbs over 158 points on buying in tech and IT shares

Rediff.com4 Dec 2025

Tata Consultancy Services, Tech Mahindra, Infosys, HCL Tech, Bharti Airtel, Sun Pharma, Bharat Electronics and Trent were the major gainers among Sensex scrips. However, Maruti, Eternal, Kotak Mahindra Bank and Titan were among the laggards.

Sensex jumps nearly 450 pts on buying in metal shares

Sensex jumps nearly 450 pts on buying in metal shares

Rediff.com12 Dec 2025

Among Sensex firms, Tata Steel, Eternal, UltraTech Cement, Larsen & Toubro, Maruti and Bharti Airtel were the major gainers. However, Hindustan Unilever, Sun Pharma, ITC and Asian Paints were among the laggards.

Sensex jumps over 513 points on buying in IT stocks

Sensex jumps over 513 points on buying in IT stocks

Rediff.com19 Nov 2025

From the Sensex pack, HCL Tech, Infosys, Tata Consultancy Services, Hindustan Unilever, Sun Pharma and Titan were among the biggest gainers. In contrast, Tata Motors Passenger Vehicles, Maruti, Adani Ports and Bajaj Finance were among the laggards.

Stock markets end lower in volatile trade

Stock markets end lower in volatile trade

Rediff.com24 Dec 2025

From the 30-Sensex firms, InterGlobe Aviation, Sun Pharma, Asian Paints, Reliance Industries, Hindustan Unilever, and Tata Steel were among the biggest laggards. However, Trent, UltraTech Cement, Maruti, and Power Grid were among the gainers.

Sun Pharma recalls over 34k bottles of generic drug in US

Sun Pharma recalls over 34k bottles of generic drug in US

Rediff.com11 Feb 2023

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.

Sun Pharma close to US firm buyout

Sun Pharma close to US firm buyout

Rediff.com30 Nov 2005

Sun Pharma receives USFDA nod

Sun Pharma receives USFDA nod

Rediff.com18 Nov 2010

Sun Pharmaceutical Industries said it has received approval from US health regulator to market generic Clarinex tablets and Tiazac capsules, used in treating nasal allergies and hypertension, respectively, in the American market.

Sensex drops over 331 points on last-minute selling

Sensex drops over 331 points on last-minute selling

Rediff.com24 Nov 2025

Among Sensex firms, Bharat Electronics, Mahindra & Mahindra, Tata Steel, UltraTech Cement, Bajaj Finserv and Tata Motors Passenger Vehicles were the major laggards. However, Tech Mahindra, Asian Paints, Infosys, Adani Ports, Sun Pharma and HDFC Bank were the gainers.

Caraco stalls Sun Pharma stake hike

Caraco stalls Sun Pharma stake hike

Rediff.com22 Dec 2003